-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Wan Wenhua, Mayor of Taizhou City, Leads Delegation to Visit Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Materials Biomembrane Project
Category:
发布时间：2022-12-23
【概要描述】
On December 20, Taizhou City held a field observation event for the “Three Comparisons and One Enhancement” project construction initiative. Led by Mayor Wan Wenhua and Zhang Yusong, Chairman of the Standing Committee of the Taizhou Municipal People’s Congress, the delegation visited several key projects, including those at Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd., to promote in-depth study and implementation of the spirit of the 20th National Congress of the Communist Party of China throughout the city. The visit underscored the need to act in accordance with the strategic plans and arrangements set forth by the provincial and municipal authorities, to assume proactive responsibility and take vigorous action, to continuously advance the “Three Comparisons and One Enhancement” campaign, to steadily strengthen the real economy, to achieve greater breakthroughs in building a modern industrial system, and to comprehensively promote new practices in Taizhou’s pursuit of Chinese-style modernization.
On December 20, Taizhou City held a field observation event for the “Three Comparisons and One Enhancement” project construction initiative. Led by Mayor Wan Wenhua and Zhang Yusong, Chairman of the Standing Committee of the Taizhou Municipal People’s Congress, the delegation visited several key projects, including those at Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd., to promote in-depth study and implementation of the spirit of the 20th National Congress of the Communist Party of China throughout the city. The initiative aims to ensure that all levels of government and enterprises conscientiously follow the strategic arrangements set by the provincial and municipal authorities, assume proactive responsibility, take vigorous action, continuously advance the “Three Comparisons and One Enhancement” campaign, steadily strengthen the real economy, achieve greater breakthroughs in building a modern industrial system, and comprehensively advance the new practice of Chinese-style modernization in Taizhou.
In Xinghua City, Wan Wenhua and his delegation first visited the Bosheng Medical New Materials project, which has an annual production capacity of 6,000 tons of multi-layer co-extruded medical films. The project has introduced a world-leading, turnkey production process specifically designed for biofilms, thereby filling a domestic gap in this field.
Wan Wenhua conducted a detailed review of the company’s product offerings and technological innovations, encouraging the enterprise to intensify its R&D efforts, optimize its product portfolio, and leverage innovation to set a new benchmark for innovative industrial development, thereby making a positive contribution to the high-quality development of the city’s greater health industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091